Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rank in Stocks #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Share Price
$0.16240909
Last synced: 2025-03-04
Market Cap
$35.68M
Change (1 day)
0.27%
Change (1 year)
0.00%
Country
CN
Trade Dali Pharmaceuticalco.,Ltd (603963)

Category

P/B ratio for Dali Pharmaceuticalco.,Ltd (603963)
P/B ratio as of August 2026 TTM: 0.69
According to Dali Pharmaceuticalco.,Ltd latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0.69. At the end of 2022 the company had a P/B ratio of 7.15.
P/B ratio history for Dali Pharmaceuticalco.,Ltd from 2012 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 0.69 -90.07%
2023 6.94 -3.00%
2022 7.15 54.26%
2021 4.64 27.40%
2020 3.64 -10.88%
2019 4.08 16.91%
2018 3.49 -22.46%
2017 4.51 -29.63%
2016 6.40 36.88%
2015 4.68 39.56%
2014 3.35 -4.78%
2013 3.52 -35.78%
2012 5.48 0.00%
P/B ratio for similar companies or competitors